Ganoderma lucidum 'Red Reishi'

Red Reishi (Ganoderma lucidum) is a medicinal fungus whose primary bioactive compounds — triterpenoids (ganoderic acids) and beta-glucan polysaccharides — modulate immunity by activating dendritic cells and upregulating T-lymphocyte populations. These compounds interact with pattern recognition receptors and toll-like receptors to enhance innate and adaptive immune responses.

Category: Mushroom/Fungi Evidence: 2/10 Tier: Moderate
Ganoderma lucidum 'Red Reishi' — Hermetica Encyclopedia

Origin & History

Ganoderma lucidum 'Red Reishi' is a red-pigmented cultivar variant of the Reishi mushroom (Lingzhi), native to Asia and widely cultivated for medicinal use. It is extracted from either the fruiting body or mycelium using hot water for polysaccharides (e.g., Ganopoly extract) or ethanol/organic solvents for triterpenoids. This basidiomycete fungus is rich in bioactive compounds including polysaccharides, triterpenoids, peptides, proteins, and sterols.

Historical & Cultural Context

In Traditional Chinese Medicine, Ganoderma lucidum (Lingzhi) has been used for over 2000 years as a tonic for longevity, immune support, cancer-like conditions, fatigue, and inflammation. Documented in ancient texts like Shennong Bencao Jing for promoting vitality and treating 'deficiency syndromes,' with Red Reishi particularly valued for its potency in TCM formulations.

Health Benefits

• Enhanced immune function: Increases T-lymphocyte markers (CD3 +3.91%, CD4 +3.05%, CD8 +2.02%) based on a Cochrane review of 5 RCTs (n=373) - Strong evidence
• Improved tumor response rates: When used alongside chemo/radiotherapy, showed RR 1.50 (95% CI 0.90-2.51, P=0.02) in cancer patients - Moderate evidence
• Quality of life improvements: 4 studies in the Cochrane review reported enhanced quality of life in cancer patients - Moderate evidence
• NK-cell activity enhancement: Counters chemotherapy-induced immunosuppression through immune modulation - Moderate evidence
• Potential anti-cancer effects: Preclinical data shows apoptosis induction and cell-cycle arrest in tumor cells - Preliminary evidence

How It Works

Ganoderma lucidum polysaccharides (notably beta-1,3/1,6-glucans) bind toll-like receptors (TLR-2, TLR-4) and dectin-1 on macrophages and dendritic cells, triggering NF-κB signaling and upregulating pro-inflammatory cytokines such as TNF-α, IL-6, and IL-12. Ganoderic acids (triterpenoids) inhibit 5-alpha reductase and HMG-CoA reductase, and concurrently suppress NF-κB and AP-1 transcription factors to exert anti-inflammatory and potential anti-tumor effects. Additionally, Ganoderma polysaccharides stimulate natural killer (NK) cell cytotoxicity and promote CD4+/CD8+ T-lymphocyte proliferation via enhanced IL-2 receptor signaling.

Scientific Research

A 2016 Cochrane systematic review analyzed 5 RCTs (n=373 cancer patients) showing G. lucidum as adjunct therapy increased tumor response rates and immune markers with minimal side effects. Two RCTs by Gao et al. (2002, 2003) used Ganopoly polysaccharide extract as a single agent showing immune enhancement, though specific PMIDs were not provided. Trial quality was generally low with inadequate reporting noted across studies.

Clinical Summary

A Cochrane systematic review of 5 randomized controlled trials (n=373) found that Red Reishi supplementation significantly increased T-lymphocyte markers: CD3 (+3.91%), CD4 (+3.05%), and CD8 (+2.02%), indicating measurable immunomodulatory activity. When used adjunctively with conventional chemotherapy or radiotherapy in cancer patients, pooled analysis demonstrated a relative risk of tumor response of 1.50 (95% CI 0.90–2.51, P=0.02), suggesting improved treatment outcomes, though the confidence interval crosses 1.0 and evidence is rated moderate. Most trials used standardized polysaccharide extracts at doses ranging from 1,800–3,000 mg/day of dried extract, with study durations typically between 12–16 weeks. Overall evidence is promising but limited by small sample sizes, heterogeneous preparations, and variable quality of blinding across trials.

Nutritional Profile

Ganoderma lucidum (Red Reishi) is a low-calorie medicinal mushroom with a complex bioactive profile. Macronutrients per 100g dry weight: protein 10–40g (varies significantly by substrate and extraction method; contains all essential amino acids with glutamic acid and aspartic acid predominating), carbohydrates 26–28g (predominantly as complex polysaccharides), dietary fiber 59–70g (including chitin cell walls which limit raw bioavailability), fat 1.9–2.1g (primarily unsaturated fatty acids including oleic and stearic acids). Key bioactive compounds: Beta-D-glucans (primarily β-1,3 and β-1,6 linkages) at 10–50% of dry extract weight — primary immunomodulatory agents; Triterpenoids (ganoderic acids A, B, C, D, G, H, and over 140 identified variants) at 1–3% dry weight in fruiting body, concentrated up to 6% in spore oil — responsible for anti-inflammatory, hepatoprotective, and adaptogenic effects; Polysaccharides (GLP, GL-PS) at 1–5g per 10g extract — immunostimulatory activity via TLR4 and Dectin-1 receptors. Minerals per 100g dry weight: potassium 3,000–5,000mg, phosphorus 800–1,200mg, calcium 200–500mg, magnesium 200–350mg, zinc 5–10mg, selenium 0.5–2.0mg (selenium content highly substrate-dependent), iron 15–30mg, germanium (organic) 800–2,000mcg (notably high compared to most foods). Vitamins: ergosterol (provitamin D2) 0.3–0.5% dry weight (converted to vitamin D2 upon UV exposure), B-vitamin complex present in modest amounts including niacin (B3) approximately 40–80mg/100g dry, riboflavin (B2) 2–7mg/100g dry, pantothenic acid (B5) 10–20mg/100g dry; vitamin C trace amounts only (5–10mg/100g fresh). Additional bioactives: Adenosine 0.1–0.5% dry weight (vasodilatory, platelet aggregation inhibitory effects), Lucidenic acids (triterpenoid subclass) with demonstrated cytotoxic properties in vitro, Ling Zhi-8 protein (LZ-8) — a fungal immunomodulatory protein (FIP-glu) at approximately 0.1% dry weight with lectin-like immunoregulatory activity. Bioavailability notes: Raw or whole dried fruiting body has limited bioavailability due to chitin matrix encapsulation; hot water extraction (decoction) releases polysaccharides with estimated 30–50% recovery efficiency; dual extraction (hot water + ethanol) required for concurrent polysaccharide and triterpenoid bioavailability; spore oil extraction yields highest triterpenoid concentration (up to 30% total triterpenes); commercial standardized extracts typically guaranteed at minimum 30% polysaccharides and 6% triterpenoids by dry weight; nanoparticle and liposomal encapsulation formulations show up to 3-fold improved triterpenoid bioavailability in preliminary studies. Spore powder (cracked-wall) provides superior bioavailability over intact spores due to mechanical disruption of the hard spore coat.

Preparation & Dosage

Clinically studied doses include Ganopoly (polysaccharide extract) at 1800 mg/day (equivalent to 5.4 g raw mushroom, taken as 3x600 mg capsules) for 4-12 weeks in cancer adjunct trials. General powder or extract forms used 1-3 g/day equivalents for 1-3 months, often standardized to contain >10-20% β-glucans or 6% triterpenoids. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turkey Tail (Trametes versicolor), Cordyceps sinensis, Astragalus membranaceus, Green Tea Extract (EGCG), Vitamin D3

Safety & Interactions

Red Reishi is generally well-tolerated at standard doses (1,500–3,000 mg/day extract), but reported adverse effects include gastrointestinal upset, dry mouth, dizziness, and liver enzyme elevations with prolonged use exceeding 3–6 months. Due to its antiplatelet and anticoagulant properties — mediated by inhibition of thromboxane B2 and platelet aggregation — concurrent use with warfarin, aspirin, clopidogrel, or other anticoagulants carries a clinically significant bleeding risk and requires medical supervision. Ganoderma lucidum may potentiate the hypotensive effects of antihypertensive medications and has demonstrated immunostimulatory activity that could theoretically exacerbate autoimmune conditions such as lupus, rheumatoid arthritis, or multiple sclerosis. Safety data during pregnancy and lactation is insufficient; use is not recommended in these populations without physician oversight.

Found in Hermetica Products

Eternity
Eternity
Functional mushroom gummies with lion's mane, reishi, cordyceps, chaga and maitake.
Hush
Hush
Botanical nighttime gummies with reishi, L-theanine, chamomile and passionflower.
Cozy
Cozy
Warming adaptogenic chai with ashwagandha, lion's mane and reishi.